Promoter holding
64.27%
SP
Strides Pharma Science Limited - Due diligence report
A 360° intelligence report on Strides: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Strides — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Strides is assessed as Moderate with a Trust Score of 74/100. Strides is an active public limited indian non-government company incorporated in 1990, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 21 Jul 2026 from the latest processed filings. Strides Pharma Science Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
42/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 2 open (1,880.26 cr) · 272 satisfied (11,468.30 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 22 | 48.0 cr |
| State Bank Of India | 19 | 48.0 cr |
| Axis Bank Limited | 13 | 48.0 cr |
| Yes Bank Limited | 10 | 48.0 cr |
| State Bank Of Travancore | 12 | 48.0 cr |
| Axis Trustee Services Limited | 1 | 48.0 cr |
Compliance Score: 42/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: EPFO, NSDL.
- Litigation present in 4 court forum(s).
- Delayed payments to MSME suppliers disclosed (8784 disclosure(s)).
- 6 active GST registration(s).
Legal cases on record (4)
05
Director Intelligence
Stability score: 75/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HOMI RUSTAM KHUSROKHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BADREE KOMANDUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BADREE KOMANDUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBIR CHAKRABORTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMEET PRATAPSINH HARIANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ADITYA ARUN KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUKTA MALIK ARORA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KAUSALYA SANTHANAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANJULA RAMAMURTHY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARUN KUMAR PILLAI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vikesh Kumar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 11 directors on the board.
- No disqualified or deactivated DINs.
- 4 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
3
Capital events
88 allotment(s) · 1 transfer(s)
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Altima Innovations, Inc. | Subsidiary Company | 74.00% |
| Arrow Life Sciences (malaysia) Sdn. Bhd | Subsidiary Company | 74.00% |
| Arco Lab Private Limited | Subsidiary Company | 74.00% |
| Generic Partners Uk Ltd | Subsidiary Company | 74.00% |
| Pharmapar Inc | Subsidiary Company | 74.00% |
| Stelis Biopharma (malaysia) Sdn. Bhd. | Subsidiary Company | 74.00% |
| Strides Arcolab International Limited | Subsidiary Company | 74.00% |
| Strides Lifesciences Limited | Subsidiary Company | 74.00% |
| Strides Netherlands B.v. | Subsidiary Company | 74.00% |
| Strides Nordic Aps | Subsidiary Company | 74.00% |
Key managerial personnel: BADREE KOMANDUR (Managing Director) · BADREE KOMANDUR (CEO) · ADITYA ARUN KUMAR (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 36+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (42/100).
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 44.33 cr.
4 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence66/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 1,880.26 cr already registered.
- Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events09 Nov 2025
Charge satisfied
Hdfc Bank Limited
27 Oct 2025
Charge satisfied
Others
30 Sep 2025
Charge satisfied
Karnataka Bank Ltd.
17 Sep 2025
Charge satisfied
Others
07 Aug 2025
Last AGM held
Annual general meeting
29 May 2025
Charge satisfied
State Bank Of India
05 Apr 2025
Director appointed
ARUN KUMAR PILLAI (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Mar 2025
Charge created
Others - 100.00 cr
18 Mar 2025
Director ceased
MUKTA MALIK ARORA
10 Feb 2025
Charge created
Karnataka Bank Ltd. - 100.00 cr
01 Feb 2025
Director appointed
MUKTA MALIK ARORA (Director)
23 Dec 2024
Charge satisfied
Others
18 Dec 2024
Charge satisfied
Others
13 Dec 2024
Charge satisfied
Yes Bank Limited
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
11 active director(s) / partner(s); board looks stable and experienced.
6 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 88 security allotment(s) - amounts available in the full report.
78 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Dhanuka Agritech | L24219HR1985PLC122802 | Dlf Qe, Haryana, India |
| Dhanuka Laboratories | U24100TN1993PLC149053 | Chennai, Tamil Nadu, India |
| Dcm Shriram Industrial Group | L74899DL1989PLC035140 | New Delhi, Delhi, India |
| Iolcp | L24116PB1986PLC007030 | Barnala, Punjab, India |
| Aarti Drugs | L37060MH1984PLC055433 | Dist Thane, Maharashtra, India |
| Deepak Fertilisers And Petrochemicals Corporation | L24121MH1979PLC021360 | Pune, Maharashtra, India |
| Simpsons | U65991TN1925PLC002345 | Chennai, Tamil Nadu, India |
| Igpetro | L51496GA1988PLC000915 | Panaji, Goa, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Strides before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Strides: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Strides - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Strides pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (4 case(s) on record), regulatory flags, charge documents trail and director networks for Strides - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Strides an active company?
Strides has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Strides financially healthy?
Strides has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Strides?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Strides?
Promoters hold the largest single block of equity - exact percentages are in the full report. 11 active director(s) are on record.
Does Strides have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 272 earlier charge(s) stand satisfied.
Is Strides up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Strides?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
